Zymofix Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.62M

  • Investors
  • 7

Zymofix General Information

Description

Developer of microbial enzyme products designed to replace chemical inputs in industrial and agricultural processes. The company offers high-purity enzymes produced through proprietary fermentation, customizable formulations, and decentralized production capabilities, enabling agricultural and industrial clients to adopt sustainable, efficient, and scalable alternatives that improve process performance and reduce environmental impact.

Contact Information

Website
www.zymofix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kerrebroek 66B
  • 9850 Deinze
  • Belgium
Primary Industry
Specialty Chemicals
Corporate Office
  • Kerrebroek 66B
  • 9850 Deinze
  • Belgium

Zymofix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymofix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 25-Aug-2026 $4.62M Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Early Stage VC 12-Nov-2024 Completed Generating Revenue
2. Grant 21-Jun-2023 $2.7M $283K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2022 $283K $283K Completed Generating Revenue
To view Zymofix’s complete valuation and funding history, request access »

Zymofix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Preferred
Preference
Ordinary
Preference 26,839 $11.55 $11.55 1x $11.55 8.14%
Ordinary 19,638 $11.55 $11.55 1x $11.55 5.96%
To view Zymofix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Zymofix Patents

Zymofix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024170736-A1 Microbial and nutrient delivery system Inactive 17-Feb-2023

Zymofix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymofix Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
First Imagine! Ventures Venture Capital Minority
High-Tech Gründerfonds Venture Capital Minority
The Nest Family Office Family Office Minority
VP Capital (Goirle) Family Office Minority
European Innovation Council Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Zymofix FAQs

  • When was Zymofix founded?

    Zymofix was founded in 2022.

  • Where is Zymofix headquartered?

    Zymofix is headquartered in Deinze, Belgium.

  • What is the size of Zymofix?

    Zymofix has 35 total employees.

  • What industry is Zymofix in?

    Zymofix’s primary industry is Specialty Chemicals.

  • Is Zymofix a private or public company?

    Zymofix is a Private company.

  • What is the current valuation of Zymofix?

    The current valuation of Zymofix is .

  • What is Zymofix’s current revenue?

    The current revenue for Zymofix is .

  • How much funding has Zymofix raised over time?

    Zymofix has raised $7.07M.

  • Who are Zymofix’s investors?

    First Imagine! Ventures, High-Tech Gründerfonds, The Nest Family Office, VP Capital (Goirle), and European Innovation Council are 5 of 7 investors who have invested in Zymofix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process